BLPH DCF Valuation - Bellerophon Therapeutics Inc

B

Watchlist Manager

Watchlist

Price: 0.1025 USD Market Closed

Market Cap: $146.8k

	Bellerophon Therapeutics Inc OTC:BLPH	US
W	Wells Fargo & Co XMUN:NWT	US
	Innovative Solutions and Support Inc NASDAQ:ISSC	US
	Cascades Inc TSX:CAS	CA
	Telstra Corporation Ltd ASX:TLS	AU
T	Thanapiriya PCL SET:TNP	TH
	Burkhalter Holding AG SIX:BRKN	CH
	Compagnie Financiere Richemont SA SIX:CFR	CH
	OneMain Holdings Inc NYSE:OMF	US
	TOPPAN Holdings Inc SWB:TPX	JP
	Delta Technologies Nyrt F:E8E4	HU
C	Canadian Tire Corporation Ltd XMUN:YAAA	CA
R	Refrigeration Electrical Engineering Corp VN:REE	VN
V	Vishay Intertechnology Inc SWB:VHY	US
R	Renault SA OTC:RNSDF	FR
	Shoper SA F:8FF	PL
I	Ibersol SGPS SA ELI:IBS	PT
G	Goldwind Science & Technology Co Ltd XMUN:CXGH	CN
N	Norditek Group AB F:O5D	SE
L	Linde PLC LSE:0M2B	UK

BLPH's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.